Details of the Drug Reposition

General Information of This Drug (ID: DMJO402)

• Drug Name: Anti-LAG3 (DMJO402)

Information on Drug Reposition of This Drug

3 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastric adenocarcinoma	DISWWLTC	2B72	Phase 2	[1]
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 2	[1]
Renal cell carcinoma	DISQZ2X8	2C90	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)